MARKET

MSLE

MSLE

Satellos Bioscience Inc
NASDAQ
7.69
+0.55
+7.70%
Closed 17:08 05/08 EDT
OPEN
7.08
PREV CLOSE
7.14
HIGH
7.81
LOW
7.08
VOLUME
32.27K
TURNOVER
76.46K
52 WEEK HIGH
13.39
52 WEEK LOW
4.680
MARKET CAP
160.19M
P/E (TTM)
-4.5126
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MSLE last week (0427-0501)?
Weekly Report · 05/04 09:15
Guggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23
Benzinga · 04/28 15:26
Satellos initiated with a Buy at Guggenheim
TipRanks · 04/28 11:00
Weekly Report: what happened at MSLE last week (0420-0424)?
Weekly Report · 04/27 09:15
Satellos publishes investor presentation on SAT-3247 muscle regeneration approach for Duchenne dystrophy
PUBT · 04/22 23:04
Oppenheimer Keeps Their Buy Rating on Satellos Bioscience (MSLE)
TipRanks · 04/20 12:23
Weekly Report: what happened at MSLE last week (0413-0417)?
Weekly Report · 04/20 09:14
Weekly Report: what happened at MSLE last week (0406-0410)?
Weekly Report · 04/13 09:15
More
About MSLE
Satellos Bioscience Inc. is a Canada-based clinical-stage drug development company. The Company is focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, the Company has developed SAT-3247, a first-of-its-kind, orally administered small molecule drug designed to address deficits in muscle repair and regeneration. SAT-3247 targets AAK1, a key protein that has identified as capable of replacing the signal normally provided by dystrophin in muscle stem cells to effect repair and regeneration. It is also leveraging its proprietary discovery platform MyoReGenX to identify additional muscle diseases or injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and represent future clinical development opportunities. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process.

Webull offers Satellos Bioscience Inc stock information, including NASDAQ: MSLE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MSLE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MSLE stock methods without spending real money on the virtual paper trading platform.